Literature DB >> 22416080

Galectin-1 markedly reduces the incidence of resorptions in mice missing immunophilin FKBP52.

Yasushi Hirota1, Kristin E Burnum, Nuray Acar, Gabriel A Rabinovich, Takiko Daikoku, Sudhansu K Dey.   

Abstract

Progesterone (P(4)) signaling is critical for pregnancy. We previously showed that immunopilin FK506 binding protein (FKBP)52 serves as a cochaperone to optimize progesterone receptor (PR) function in the uterus, and its deficiency leads to P(4) resistance in a pregnancy stage-specific and genetic background-dependent manner in mice. In particular, sc placement of SILASTIC implants carrying P(4) rescued implantation failure in CD1 Fkbp52(-/-) mice, but the resorption rate was substantially high at midgestation due to reduced P(4) responsiveness. Because downstream targets of P(4)-FKBP52-PR signaling in the uterus to support pregnancy are not clearly understood, we performed proteomic analysis using Fkbp52(-/-), PR-deficient (Pgr(-/-)), and wild-type (WT) uteri. We found that the expression of galectin-1 (Gal1), an evolutionarily conserved glycan-binding protein, was significantly down-regulated in both Fkbp52(-/-) and Pgr(-/-) uteri compared with WT uteri. During early gestation, Lgals1, which encodes Gal1, was distinctly expressed in stromal and decidual cells. Lgals1 expression was much lower in d 4 Fkbp52(-/-) uteri compared with WT uteri, and this reduction was reversed by P(4) supplementation. More interestingly, concomitant supplementation of recombinant Gal1 significantly suppressed the high resorption rate and leukocyte infiltration at implantation sites in CD1 Fkbp52(-/-) females carrying P(4) SILASTIC implants. These findings suggest that uterine Gal1 is an important downstream target of P(4)-FKBP52-PR signaling in the uterus to support P(4) responsiveness during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22416080      PMCID: PMC3339653          DOI: 10.1210/en.2012-1035

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  30 in total

1.  Is galectin-1 a trigger for trophoblast cell fusion?: the MAP-kinase pathway and syncytium formation in trophoblast tumour cells BeWo.

Authors:  Isabelle Fischer; Maja Weber; Christina Kuhn; Justine S Fitzgerald; Sandra Schulze; Klaus Friese; Hermann Walzel; Udo R Markert; Udo Jeschke
Journal:  Mol Hum Reprod       Date:  2011-08-10       Impact factor: 4.025

Review 2.  Tetratricopeptide repeat cochaperones in steroid receptor complexes.

Authors:  David F Smith
Journal:  Cell Stress Chaperones       Date:  2004       Impact factor: 3.667

Review 3.  Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases.

Authors:  J E Kay
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

4.  Differential expression of two beta-galactoside-binding lectins in the reproductive tracts of pregnant mice.

Authors:  B Phillips; K Knisley; K D Weitlauf; J Dorsett; V Lee; H Weitlauf
Journal:  Biol Reprod       Date:  1996-09       Impact factor: 4.285

5.  Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.

Authors:  J P Lydon; F J DeMayo; C R Funk; S K Mani; A R Hughes; C A Montgomery; G Shyamala; O M Conneely; B W O'Malley
Journal:  Genes Dev       Date:  1995-09-15       Impact factor: 11.361

6.  Galectin-1 and galectin-3 in the trophoblast of the gestational trophoblastic disease.

Authors:  M Bozić; M Petronijević; S Milenković; J Atanacković; J Lazić; Lj Vićovac
Journal:  Placenta       Date:  2004-11       Impact factor: 3.481

7.  Posttranslational regulation of IRF-4 activity by the immunophilin FKBP52.

Authors:  Y Mamane; S Sharma; L Petropoulos; R Lin; J Hiscott
Journal:  Immunity       Date:  2000-02       Impact factor: 31.745

Review 8.  Molecular cues to implantation.

Authors:  S K Dey; H Lim; Sanjoy K Das; Jeff Reese; B C Paria; Takiko Daikoku; Haibin Wang
Journal:  Endocr Rev       Date:  2004-06       Impact factor: 19.871

9.  Incidence of early loss of pregnancy.

Authors:  A J Wilcox; C R Weinberg; J F O'Connor; D D Baird; J P Schlatterer; R E Canfield; E G Armstrong; B C Nisula
Journal:  N Engl J Med       Date:  1988-07-28       Impact factor: 91.245

10.  Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: a possible ligand for interaction with blastocyst EGF-receptor in implantation.

Authors:  S K Das; X N Wang; B C Paria; D Damm; J A Abraham; M Klagsbrun; G K Andrews; S K Dey
Journal:  Development       Date:  1994-05       Impact factor: 6.868

View more
  5 in total

Review 1.  Physiological and molecular determinants of embryo implantation.

Authors:  Shuang Zhang; Haiyan Lin; Shuangbo Kong; Shumin Wang; Hongmei Wang; Haibin Wang; D Randall Armant
Journal:  Mol Aspects Med       Date:  2013-01-02

Review 2.  Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands.

Authors:  Andrzej Galat
Journal:  Cell Mol Life Sci       Date:  2012-12-08       Impact factor: 9.261

3.  Characteristic Changes in Decidual Gene Expression Signature in Spontaneous Term Parturition.

Authors:  Haidy El-Azzamy; Andrea Balogh; Roberto Romero; Yi Xu; Christopher LaJeunesse; Olesya Plazyo; Zhonghui Xu; Theodore G Price; Zhong Dong; Adi L Tarca; Zoltan Papp; Sonia S Hassan; Tinnakorn Chaiworapongsa; Chong Jai Kim; Nardhy Gomez-Lopez; Nandor Gabor Than
Journal:  J Pathol Transl Med       Date:  2017-02-22

Review 4.  Role of galectin-glycan circuits in reproduction: from healthy pregnancy to preterm birth (PTB).

Authors:  Sandra M Blois; Stefan Verlohren; Gang Wu; Gary Clark; Anne Dell; Stuart M Haslam; Gabriela Barrientos
Journal:  Semin Immunopathol       Date:  2020-06-29       Impact factor: 9.623

Review 5.  Galectins: Important Regulators in Normal and Pathologic Pregnancies.

Authors:  Min Chen; Jia-Lu Shi; Zi-Meng Zheng; Zhi Lin; Ming-Qing Li; Jun Shao
Journal:  Int J Mol Sci       Date:  2022-09-03       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.